Starpharma Holdings Ltd (SPL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Starpharma Holdings Ltd (SPL) has a cash flow conversion efficiency ratio of 0.182x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$3.91 Million ≈ $2.77 Million USD) by net assets (AU$21.48 Million ≈ $15.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Starpharma Holdings Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Starpharma Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Starpharma Holdings Ltd total liabilities for a breakdown of total debt and financial obligations.
Starpharma Holdings Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Starpharma Holdings Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PTC India Financial Services Limited
NSE:PFS
|
0.392x |
|
Blue Acquisition Corp. Class A Ordinary Shares
NASDAQ:BACC
|
0.000x |
|
Creative Sensor Inc
TW:8249
|
0.036x |
|
Kore Potash Plc
AU:KP2
|
-0.004x |
|
Virginia National Bankshares Corp
NASDAQ:VABK
|
0.035x |
|
Red Hill Minerals Ltd
AU:RHI
|
0.084x |
|
Innowireless Co. Ltd
KQ:073490
|
-0.017x |
|
Exel Industries
PA:EXE
|
-0.052x |
Annual Cash Flow Conversion Efficiency for Starpharma Holdings Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Starpharma Holdings Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Starpharma Holdings Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$19.00 Million ≈ $13.44 Million |
AU$-6.76 Million ≈ $-4.78 Million |
-0.356x | -43.37% |
| 2024-06-30 | AU$28.12 Million ≈ $19.89 Million |
AU$-6.98 Million ≈ $-4.94 Million |
-0.248x | +36.16% |
| 2023-06-30 | AU$34.81 Million ≈ $24.63 Million |
AU$-13.53 Million ≈ $-9.58 Million |
-0.389x | -42.92% |
| 2022-06-30 | AU$48.39 Million ≈ $34.24 Million |
AU$-13.16 Million ≈ $-9.31 Million |
-0.272x | -14.43% |
| 2021-06-30 | AU$62.30 Million ≈ $44.08 Million |
AU$-14.81 Million ≈ $-10.48 Million |
-0.238x | +30.90% |
| 2020-06-30 | AU$31.33 Million ≈ $22.17 Million |
AU$-10.78 Million ≈ $-7.62 Million |
-0.344x | -40.99% |
| 2019-06-30 | AU$42.40 Million ≈ $30.00 Million |
AU$-10.34 Million ≈ $-7.32 Million |
-0.244x | -27.43% |
| 2018-06-30 | AU$53.28 Million ≈ $37.70 Million |
AU$-10.20 Million ≈ $-7.22 Million |
-0.191x | +31.13% |
| 2017-06-30 | AU$60.98 Million ≈ $43.15 Million |
AU$-16.95 Million ≈ $-12.00 Million |
-0.278x | +22.85% |
| 2016-06-30 | AU$49.42 Million ≈ $34.97 Million |
AU$-17.81 Million ≈ $-12.60 Million |
-0.360x | +0.59% |
| 2015-06-30 | AU$37.56 Million ≈ $26.57 Million |
AU$-13.62 Million ≈ $-9.63 Million |
-0.363x | -21.73% |
| 2014-06-30 | AU$32.95 Million ≈ $23.31 Million |
AU$-9.81 Million ≈ $-6.94 Million |
-0.298x | -39.76% |
| 2013-06-30 | AU$45.97 Million ≈ $32.53 Million |
AU$-9.79 Million ≈ $-6.93 Million |
-0.213x | -6.11% |
| 2012-06-30 | AU$48.65 Million ≈ $34.42 Million |
AU$-9.77 Million ≈ $-6.91 Million |
-0.201x | +14.13% |
| 2011-06-30 | AU$27.69 Million ≈ $19.59 Million |
AU$-6.48 Million ≈ $-4.58 Million |
-0.234x | -124.47% |
| 2010-06-30 | AU$34.84 Million ≈ $24.65 Million |
AU$-3.63 Million ≈ $-2.57 Million |
-0.104x | +34.07% |
| 2009-06-30 | AU$25.50 Million ≈ $18.04 Million |
AU$-4.03 Million ≈ $-2.85 Million |
-0.158x | +39.82% |
| 2008-06-30 | AU$20.38 Million ≈ $14.42 Million |
AU$-5.35 Million ≈ $-3.79 Million |
-0.263x | -99.82% |
| 2007-06-30 | AU$25.72 Million ≈ $18.20 Million |
AU$-3.38 Million ≈ $-2.39 Million |
-0.131x | +62.60% |
| 2006-06-30 | AU$21.32 Million ≈ $15.08 Million |
AU$-7.49 Million ≈ $-5.30 Million |
-0.351x | +39.71% |
| 2005-06-30 | AU$9.97 Million ≈ $7.05 Million |
AU$-5.81 Million ≈ $-4.11 Million |
-0.583x | -76.57% |
| 2004-06-30 | AU$17.59 Million ≈ $12.45 Million |
AU$-5.81 Million ≈ $-4.11 Million |
-0.330x | +22.04% |
| 2002-06-30 | AU$17.27 Million ≈ $12.22 Million |
AU$-7.31 Million ≈ $-5.17 Million |
-0.423x | -329.93% |
| 2001-06-30 | AU$24.92 Million ≈ $17.63 Million |
AU$-2.45 Million ≈ $-1.74 Million |
-0.098x | -- |
About Starpharma Holdings Ltd
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally. The company's products include VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurr… Read more